Archy Raises $50M Series C+ Led by JMI Equity for AI Dental Practice Platform

Archy Raises $50M Series C+ Led by JMI Equity

Archy, an AI software company serving dental practices, has raised $50 million in a Series C+ round. JMI Equity led the financing, which was announced on September 11, 2026.

What Archy Does

Archy provides a cloud-based platform built for dental practices. The platform automates core operational workflows, including:

• Scheduling
• Charting
• Imaging
• Billing
• Messaging

The company's stated goal is to replace the multiple disconnected tools that dental practices typically rely on with a single AI-powered platform. By consolidating these functions, Archy aims to streamline day-to-day practice operations.

Company Background

Archy was founded in 2021 by Jonathan Rat, a former product manager at Meta, Uber, and SurveyMonkey. The company operates in the dental software space, where practice management has historically been fragmented across separate systems for scheduling, clinical documentation, imaging, and revenue cycle tasks.

The Round

• Round type: Series C+
• Amount raised: $50,000,000 USD
• Announcement date: September 11, 2026
• Lead investor: JMI Equity
• Participating investors: Entree Capital, Alven, CRV, JMI Equity, TCV, Bessemer Venture Partners

The round brings together a mix of existing and new backers, with JMI Equity taking the lead position. The presence of TCV and Bessemer Venture Partners alongside earlier-stage investors such as Entree Capital, Alven, and CRV suggests continued support across the company's funding history.

Why It Matters

Dental practices have long been a target for vertical software consolidation. A typical practice may run separate systems for patient scheduling, clinical charting, imaging capture, insurance billing, and patient communication. Each handoff between those systems creates administrative overhead and potential for error.

Archy's pitch is that a single AI-powered platform can absorb those workflows and reduce the operational burden on practice staff. The Series C+ designation indicates the company has moved well beyond early product validation and is now focused on scaling.

Acquisition Angle

The $50 million Series C+ led by JMI Equity positions Archy as a scaled asset in the dental practice management software category. For strategic acquirers and investors tracking vertical SaaS consolidation, several factors stand out:

• Category consolidation thesis: Archy is explicitly positioned against fragmented point solutions, which aligns with the broader trend of platform consolidation in healthcare vertical software.
• Investor syndicate: A lead position from JMI Equity, alongside TCV and Bessemer Venture Partners, signals institutional confidence at a later stage.
• Founder profile: Jonathan Rat's product background at Meta, Uber, and SurveyMonkey provides a consumer-scale product perspective applied to a vertical software market.
• Stage: A Series C+ round typically indicates a company with established revenue and a focus on expansion rather than initial product-market fit.

What to Watch

With this financing, Archy has additional capital to expand its AI-powered platform across dental practices. The key questions for observers will be how quickly the company converts the fragmented dental software market toward a single-platform model, and how the investor syndicate's later-stage backers shape the company's path toward scale.

For acquisition-oriented readers, Archy now sits in a later-stage funding tier with a named lead investor and a defined vertical focus — a combination that makes it a relevant name to track in dental and healthcare practice management software.